Eurazeo has held the final closing of its Eurazeo Capital V fund (EC-V) with €3bn in total capital commitments, exceeding its initial target and reinforcing investor confidence in its mid-large buyout (MLBO) strategy.
The successful fundraise marks a significant milestone for Eurazeo’s mid-market investment strategy, which focuses on high-growth companies with global ambitions.
EC-V targets mid-market businesses across Europe and North America, with individual equity investments ranging from €200m to €350m. The fund primarily invests in three key sectors: tech-enabled business services; financial services; and healthcare & life sciences.
With nearly 50% of its capital already deployed, EC-V has made six investments: Mapal – a Spanish back-of-house software provider for the food service and hospitality sector; Eres – a French advisory firm specialising in employee profit-sharing and retirement plans; BMS – a UK and US-based independent specialty insurance broker; Cranial Technologies – a global leader in plagiocephaly treatments; Sevetys – a major French veterinary clinic group; and Scaled Agile – a business agility solutions specialist.
EC-V’s successful fundraising builds on the strong track record of its predecessor, Eurazeo Capital IV (EC-IV).
Eurazeo’s MLBO team, consisting of nearly 30 investment professionals across Paris, London, Milan, and New York, secured commitments from a diverse group of global investors, including insurance companies, sovereign wealth funds, pension funds, banks, and family offices.
